Public Site       

For Healthcare professionals only

 

Loading......

  • HCP Home
  • Prevalence & burden
    • Prevalence & burden
    • How common is HF & what is the burden on society?
  • HF Definition and Diagnosis
    • HF Definition and Diagnosis
    • Definition, causes & symptoms
    • HF in T2D
    • HFpEF Calculator
  • Changing the Future
    • Changing the Future
    • The unmet need in heart failure
    • Challenging heart failure
  • Resources
    • Resources
    • Resources for your patients
  • Heart Failure Academy
  • More Hide

    Title

    Thank you for visiting the Spotlight On Heart Failure website.

    This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

    Do you wish to continue?

    CANCEL CONTINUE

    Title

    Thank you for visiting the Spotlight On Heart Failure website.

    This link will take you to a website not owned by AstraZeneca. AstraZeneca provides this link as a service to our site visitors. AstraZeneca are not responsible for the content or privacy / legal policies of any third party websites.

    Do you wish to continue?

    CANCEL CONTINUE
     

    Validating...

    Welcome to the AstraZeneca Medicines Site

    This site is intended for healthcare professionals only. 

    TAKE ME TO THE GENERAL PUBLIC SITE

     

    This site is intended for healthcare professionals.
    This material is offered as an unrestricted grant by the company: AstraZeneca. This material is not owned or developed by the company and does not promote the use of any of its products. The materials is not monitored by the company and the company is not responsible for it

     

    AstraZeneca من اجل مراقبه سلامه منتجات
    نشجع للابلاغ عن اى اثار جانبيه تحدث اثناء تناول 
    AstraZeneca منتجات

    للبريد الالكترونى
    patient.safetyegypt@astrazeneca.com

    للمزيد من المعلومات الطبيه يرجى الارسال الى
    medinfo-egypt@astrazeneca.com

    • About Spotlight on Heart Failure
    • Privacy notice
    • Contact us
    • Legal notice and terms of use
    • Cookie notice
    • سياسة الكوكيز


    Bureau 58, Building B, Floor 2, Plot No. 58,
    4th Sector,  Fifth settlement, New Cairo, Egypt

    #spotlightonheartfailure

    AstraZeneca Veeva Document ID: EG-8608

    Date of Preparation: March 2022

    Date of Expiry:February 2023

    @2022 AstraZeneca. All rights reserved.

     

    Loading......

     

     

     

     

    EDA Notification no.: ONA4127-01092025
    In-validation date 01/09/2026

    Back to top